SPR phase interrogation via dark-pixel-ratio orientation analysis in common-path vortex interferometry
Optics Letters · 01.07.2026 · 51 (13) · 3709
DOI: 10.1364/ol.601675 ↗Kurz gefasst
Fachartikel in der Zeitschrift Optics Letters, online erschienen am 29.06.2026. Verfasst von Jiun-You Lin und 1 weiteren Autor:innen. Die Arbeit nennt 11 Literaturangaben. Gefördert von: National Science and Technology Council.
Abstract (Originalsprache)
We present a surface plasmon resonance (SPR) phase interrogation technique based on common-path vortex interferometry, implemented with angle-scanning measurements. The SPR-induced differential phase is encoded in the azimuthal orientation of a central dark fringe formed by interference between beams with opposite topological charges. Conventional lobe-centroid tracking suffers from systematic errors caused by beam translation, resulting in a root-mean-square error (RMSE) of 9.85°. To address this, we use a dark-pixel ratio (DPR) method to retrieve fringe orientation. By analyzing the azimuthal distribution of dark pixels with Gaussian fitting, the phase is robustly retrieved despite intensity asymmetries, reducing the RMSE to 2.81°. This stable approach, which requires no electronic modulators, enables high-precision SPR phase measurements.
Förderung
- National Science and Technology Council
Zitieren
APA
Lin, J. Y., & Tseng, C. Y. (2026). SPR phase interrogation via dark-pixel-ratio orientation analysis in common-path vortex interferometry. Optics Letters, 51(13), 3709. https://doi.org/10.1364/ol.601675
Vancouver
Lin JY, Tseng CY. SPR phase interrogation via dark-pixel-ratio orientation analysis in common-path vortex interferometry. Optics Letters. 2026;51(13):3709. doi:10.1364/ol.601675
BibTeX
@article{Lin2026,
author = {Lin, Jiun-You and Tseng, Chuan-Yu},
title = {SPR phase interrogation via dark-pixel-ratio orientation analysis in common-path vortex interferometry},
journal = {Optics Letters},
year = {2026},
volume = {51},
number = {13},
pages = {3709},
doi = {10.1364/ol.601675}
}
EUVIMED